Email alerts
Advanced Search
  • Jan 16, 2014
    Covidien Declares Quarterly Cash Dividend

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

  • Jan 15, 2014
    Medtronic to Appeal Federal District Court Verdict

    MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...

  • Jan 15, 2014
    Covidien Completes Sale of Confluent Surgical to Integra LifeSciences

    DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

  • Jan 14, 2014
    HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
    Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012

    HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

  • Jan 13, 2014
    Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’
    Brazil Acquisition, China Joint Venture Enable Company to Address Underserved Markets, Expand Patient Access to Care

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...

Show 5102550100 per page